Baird Medical Investment Holdings Limited (BDMD)

BDMD Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	-	0.18	2.97	1.51	1.71	3.28
Short-Term Investments	-	0.24	0.3	0.12	0.2	0.16
Cash & Short-Term Investments	-	0.42	3.27	1.63	1.91	3.44
Cash Growth	-	-87.17%	100.25%	-14.52%	-44.55%	202.84%
Accounts Receivable	30.68	42.53	46.58	31.1	24.37	12.45
Other Receivables	0	0	0	0	0.39	1.02
Receivables	30.68	42.53	46.58	31.1	24.76	13.47
Inventory	1.03	1.09	1.3	1.14	1.29	1.67
Prepaid Expenses	-	-	-	-	-	2.37
Restricted Cash	0.29	0.39	-	-	-	-
Other Current Assets	13.08	10.55	10.27	6.21	5.8	1.44
Total Current Assets	45.09	54.97	61.42	40.08	33.76	22.41
Property, Plant & Equipment	-	6.55	7.62	7	2.73	3.33
Goodwill	-	0.06	0.06	0.06	0.06	0.07
Other Intangible Assets	-	0.01	0.02	0.03	0.05	0.06
Long-Term Deferred Tax Assets	-	0.76	0.71	0.81	0.21	0.18
Long-Term Deferred Charges	-	-	-	0.88	-	-
Other Long-Term Assets	28.76	7.35	8.14	7.85	5.81	0.09
Total Assets	73.85	69.7	77.96	56.71	42.62	26.13

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	1.34	1.81	1.25	0.55	0.22	0.34
Accrued Expenses	13.35	4.65	5.04	1.94	1.8	0.72
Short-Term Debt	10.76	10.43	16.17	8.17	6.23	15.79
Current Portion of Long-Term Debt	3.32	2.64	0.87	0.82	-	-
Current Portion of Leases	0.14	0.21	0.37	0.5	0.39	0.37
Current Income Taxes Payable	-	0.46	0.08	0.45	0.71	0.42
Current Unearned Revenue	2.44	0.79	0.79	0.5	0.69	0.64
Other Current Liabilities	3.54	11.37	10.01	5.96	5.96	2.54
Total Current Liabilities	34.9	32.36	34.62	18.98	16.02	20.82
Long-Term Debt	-	6.09	3.44	1.61	-	-
Long-Term Leases	-	0.03	0.14	0.41	0.82	0.45
Long-Term Deferred Tax Liabilities	-	-	-	-	-	0.02
Total Liabilities	39.22	38.48	38.2	21	16.84	21.28

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0	0	0	0	0	0.01
Additional Paid-In Capital	31.04	28.66	11.44	18.85	18.85	-
Retained Earnings	4.11	4.08	31.36	18.9	8.36	-3.71
Comprehensive Income & Other	-0.39	-1.37	-3.14	-2.01	-1.28	8.9
Total Common Equity	34.77	31.37	39.66	35.75	25.93	5.21
Minority Interest	-0.15	-0.14	0.1	-0.04	-0.16	-0.36
Shareholders' Equity	34.63	31.22	39.76	35.71	25.78	4.85
Total Liabilities & Equity	73.85	69.7	77.96	56.71	42.62	26.13

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	14.22	19.39	20.98	11.51	7.44	16.61
Net Cash (Debt)	-14.22	-18.97	-17.72	-9.88	-5.53	-13.17
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-	-0.68	-0.81	-0.48	-0.22	-0.01
Filing Date Shares Outstanding	-	30.81	26.84	29.41	25.56	1,181
Total Common Shares Outstanding	-	20.58	25.56	29.41	25.56	1,181
Working Capital	10.18	22.61	26.79	21.11	17.74	1.58
Book Value Per Share	-	1.52	1.55	1.22	0.88	0.00
Tangible Book Value	34.77	31.3	39.58	35.67	25.82	5.08
Tangible Book Value Per Share	-	1.52	1.55	1.21	0.88	0.00
Machinery	-	7.78	7.41	5.06	1.53	1.59
Leasehold Improvements	-	4.52	4.33	4.66	2.61	2.86

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Apr 24, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 4, 2026

Data Sources Report a data error